IMCC
IMCC 1-star rating from Upturn Advisory

Im Cannabis Corp (IMCC)

Im Cannabis Corp (IMCC) 1-star rating from Upturn Advisory
$0.8
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

02/24/2026: IMCC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $8.22

1 Year Target Price $8.22

Analysts Price Target For last 52 week
$8.22 Target price
52w Low $0.77
Current$0.8
52w High $7.12
Advertisement

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 4.89M USD
Price to earnings Ratio -
1Y Target Price 8.22
Price to earnings Ratio -
1Y Target Price 8.22
Volume (30-day avg) 1
Beta 2.01
52 Weeks Range 0.77 - 7.12
Updated Date 02/24/2026
52 Weeks Range 0.77 - 7.12
Updated Date 02/24/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.5

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Revenue by Geography

Advertisement

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -8.97%
Operating Margin (TTM) -7.78%

Management Effectiveness

Return on Assets (TTM) -6.72%
Return on Equity (TTM) -119.75%

Valuation

Trailing PE -
Forward PE 16.31
Enterprise Value 16513737
Price to Sales(TTM) 0.09
Enterprise Value 16513737
Price to Sales(TTM) 0.09
Enterprise Value to Revenue 0.43
Enterprise Value to EBITDA 5.68
Shares Outstanding 5894812
Shares Floating 3087172
Shares Outstanding 5894812
Shares Floating 3087172
Percent Insiders 44.66
Percent Institutions 3.42

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Im Cannabis Corp

Im Cannabis Corp(IMCC) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Im Cannabis Corp. (CSE: IMMD, OTCQX: IMMDF) was founded in 2013. It has evolved from a Canadian cannabis producer into a multi-faceted company with a focus on the Canadian market. Key milestones include its initial public offering on the Canadian Securities Exchange (CSE) and its listing on the OTCQX Best Market in the US, aimed at increasing its investor base. The company has pursued a strategy of brand building and distribution within the regulated Canadian cannabis market.

Company business area logo Core Business Areas

  • Brand Development and Sales: Focuses on developing and marketing cannabis brands for the Canadian adult-use market. This includes creating a portfolio of flower, pre-rolls, vapes, and edibles.
  • Cultivation and Processing: While not primarily a large-scale cultivator, Im Cannabis Corp partners with licensed cultivators and processors to source and develop products for its brands.
  • Distribution and Retail Support: Aims to secure shelf space in provincial cannabis retail stores across Canada and support retail partners with product knowledge and marketing.

leadership logo Leadership and Structure

Im Cannabis Corp. is led by a management team with experience in the consumer packaged goods and cannabis industries. The exact structure involves various departments for brand management, sales, marketing, regulatory compliance, and operations. Specific leadership details would require checking the company's latest investor relations materials.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Description: RIFF is one of Im Cannabis Corp.'s flagship brands, known for its diverse range of cannabis flower and pre-roll products. The brand targets a broad consumer base with various strains and THC/CBD potencies. Competitors include numerous other licensed producers and brands in the Canadian market such as Canopy Growth (e.g., Tweed), Aurora Cannabis (e.g., San Rafael '71), and Tilray Brands (e.g., Broken Coast). Specific market share for individual brands is difficult to ascertain due to the fragmented nature of the Canadian market and limitations in publicly available granular data.
  • Product Name: RIFF - Flower and Pre-rolls
  • Description: Homestead is positioned as a more value-driven brand offering accessible cannabis flower. This segment competes directly with other budget-friendly cannabis brands and private label offerings from retailers. Competitors in this space are vast and include brands from many of the larger Canadian licensed producers aiming for different price points.
  • Product Name: Homestead - Value-oriented Flower
  • Description: YIGG aims to capture a segment of the premium flower market. This brand competes with other craft and premium cannabis brands focusing on terpene profiles, cannabinoid content, and cultivation quality. Competitors include brands like Gage Cannabis (acquired by Tilray), Flowr, and many smaller craft cultivators.
  • Product Name: YIGG: Premium Flower

Market Dynamics

industry overview logo Industry Overview

The Canadian cannabis industry is a regulated market characterized by provincial distribution systems, evolving consumer preferences, and ongoing consolidation. Challenges include oversupply, pricing pressures, and the need to compete with the illicit market. The industry is mature in terms of legal framework but continues to adapt to market demands and regulatory changes.

Positioning

Im Cannabis Corp. positions itself as a brand-centric company with a focus on developing and marketing consumer-facing cannabis products rather than solely relying on cultivation. Its competitive advantage lies in its brand portfolio, distribution partnerships, and understanding of the Canadian consumer. It aims to differentiate through product quality, brand storytelling, and strategic marketing efforts.

Total Addressable Market (TAM)

The Total Addressable Market for legal cannabis in Canada is substantial and continues to grow as more consumers shift from the illicit market and as product categories expand. While precise TAM figures fluctuate, it is in the billions of Canadian dollars annually. Im Cannabis Corp. is positioned to capture a portion of this TAM by focusing on specific consumer segments within its brand offerings and expanding its reach across Canadian provinces.

Upturn SWOT Analysis

Strengths

  • Established brand portfolio (RIFF, Homestead, YIGG)
  • Focus on consumer-facing products and brand building
  • Partnerships with licensed cultivators and processors
  • Experience in the Canadian regulated market
  • Listing on OTCQX for broader US investor access

Weaknesses

  • Reliance on third-party cultivation and processing can impact margin control
  • Competition from larger, vertically integrated licensed producers
  • Brand recognition can be challenged in a crowded market
  • Limited international market presence
  • Potential for inventory management challenges with fluctuating demand

Opportunities

  • Expansion into new product categories (e.g., beverages, concentrates)
  • Growth in provincial distribution networks
  • Potential for international market entry as regulations evolve
  • Acquisition of complementary brands or distribution channels
  • Increasing consumer adoption of premium and niche cannabis products

Threats

  • Intense competition from both legal and illicit markets
  • Regulatory changes and potential new restrictions
  • Pricing pressures and commoditization of certain product types
  • Economic downturns impacting consumer discretionary spending
  • Challenges in securing capital for growth initiatives

Competitors and Market Share

Key competitor logo Key Competitors

  • Canopy Growth Corporation (CGC)
  • Aurora Cannabis Inc. (ACB)
  • Tilray Brands, Inc. (TLRY)
  • Cronos Group Inc. (CRON)
  • Organigram Holdings Inc. (OGI)

Competitive Landscape

Im Cannabis Corp. faces intense competition from larger, well-established licensed producers with significant cultivation capacity, established brands, and extensive distribution networks. Its advantage lies in its brand-focused approach, aiming to carve out niche markets and build consumer loyalty through marketing and product innovation. However, its relatively smaller scale and reliance on third-party cultivation can be disadvantages compared to vertically integrated competitors who have more control over their supply chain and costs.

Growth Trajectory and Initiatives

Historical Growth: Historically, Im Cannabis Corp. has aimed for growth through brand development and market penetration within Canada. Growth has been tied to the expansion of the legal Canadian market and its ability to secure shelf space and consumer acceptance for its brands. Performance has been subject to the dynamic nature of the industry.

Future Projections: Future projections for Im Cannabis Corp. would depend on analyst reports and the company's strategic execution. Key growth drivers are expected to be the continued maturation of the Canadian market, expansion of product offerings, potential M&A activity, and capturing a larger share of the legal cannabis market. Expansion into new provinces and product categories are often cited as key growth avenues.

Recent Initiatives: Recent initiatives likely focus on optimizing its brand portfolio, enhancing distribution efficiencies, and potentially exploring new product formats or market segments. The company may also be undertaking efforts to improve operational profitability and strengthen its financial position.

Summary

Im Cannabis Corp. is a Canadian cannabis company focused on brand development and sales. Its strengths lie in its brand portfolio and market understanding, but it faces significant competition and operational challenges common in the evolving cannabis industry. Opportunities exist in market expansion and new product categories, while threats include regulatory shifts and intense market competition. The company needs to focus on achieving profitability and differentiating its brands effectively to thrive.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Investor Relations Filings (e.g., SEDAR, SEC EDGAR)
  • Financial News Outlets (e.g., Bloomberg, Reuters, The Wall Street Journal)
  • Industry Analysis Reports
  • Stock Market Data Providers

Disclaimers:

This JSON output is for informational purposes only and does not constitute financial advice. Data accuracy is subject to the timeliness and availability of public disclosures from Im Cannabis Corp. and other market data providers. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Market share data is estimated and can vary significantly based on reporting methodology and time period.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Im Cannabis Corp

Exchange NASDAQ
Headquaters -
IPO Launch date 2020-05-20
CEO & Executive Director Mr. Oren Shuster
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees -
Full time employees -

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.